BRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKurtulmus, Neslihan
dc.contributor.authorDuren, Mete
dc.contributor.authorInce, Umit
dc.contributor.authorYakicier, M. Cengiz
dc.contributor.authorPeker, Onder
dc.contributor.authorAydin, Ozlem
dc.contributor.authorAltiok, Ender
dc.contributor.authorGiray, Serdar
dc.contributor.authorAzizlerli, Halil
dc.date.accessioned2025-10-16T15:35:35Z
dc.date.issued2012
dc.identifier.doi10.1007/s12020-012-9651-x
dc.identifier.otherWOS:000309155900026
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9491
dc.publisherSPRINGER
dc.sourceENDOCRINE
dc.subjectBRAF\\(V600E\\) mutation
dc.subjectThyroid papillary cancer
dc.subjectThyroid papillary carcinoma
dc.titleBRAFV600E mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS